TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16924032

Group type: EXPERIMENTAL
Intervention: CSF BACE1 activity in Alzheimer disease (AD)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: CSF BACE1 activity in sporadic CJD
Number of subjects: 68
Study: 15043759

Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 12054149

Group type: EXPERIMENTAL
Intervention: Sublingual fentanyl citrate (SLFC)
Number of subjects: 11
Study: 11326965

Group type: EXPERIMENTAL
Intervention: NO inhalation (10 ppm for 30 min)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Nifedipine (10 mg, tid) in addition to conventional therapy
Number of subjects: 65

Group type: COMPARATOR
Intervention: Conventional therapy (oxygen, intravenous furosemide, aminophylline, dexamethasone)
Number of subjects: 65
Study: 7827638

Group type: EXPERIMENTAL
Intervention: Transdermal E2 (0.05 mg/24 h)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Transdermal E2 (0.05 mg/24 h) + Nomegestrol acetate (5 mg/24 h)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Baseline (before treatment)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: E2 treatment (after 2 weeks)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: E2 treatment (3rd month)
Number of subjects: 8
Study: 3287675

Group type: EXPERIMENTAL
Intervention: Aspirin 300 mg or 1,200 mg daily for a mean duration of 35 months
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (not taking aspirin)
Number of subjects: 120
Study: 49474

Group type: EXPERIMENTAL
Intervention: Guar gum
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Pectin
Number of subjects: 36

Group type: COMPARATOR
Intervention: Wheat fibre
Number of subjects: 36
Study: 31077250

Group type: EXPERIMENTAL
Intervention: Enalapril and metoprolol
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 30303905

Group type: EXPERIMENTAL
Intervention: Torsemide 20 mg/d for 5 days
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 26049866

Group type: EXPERIMENTAL
Intervention: 250 mg cranberry powder (Flowens™)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: 500 mg cranberry powder (Flowens™)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study: 23224838

Group type: EXPERIMENTAL
Intervention: Intervention group (dietary intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison group (no specific intervention details provided)
Number of subjects: 0
Study: 22271481

Group type: COMPARATOR
Intervention: Tamoxifen (TAM) for 5 years
Number of subjects: 3714

Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM) for 2 years followed by Anastrozole (ANA) for 3 years
Number of subjects: 3714
Study: 19908172

Group type: EXPERIMENTAL
Intervention: Swim recovery session (SRS) (20x100 m at 90% of 1 km time trial speed)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Passive recovery session (PRS)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Swim recovery session (SRS)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 9
Study: 17347010

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) replacement therapy
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (normative data)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Before GH replacement therapy
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: During GH replacement therapy
Number of subjects: 130
Study: 16342340

Group type: EXPERIMENTAL
Intervention: Warm blood cardioplegia
Number of subjects: 156

Group type: COMPARATOR
Intervention: Tepid blood cardioplegia
Number of subjects: 156

Group type: COMPARATOR
Intervention: Cold crystalloid cardioplegia
Number of subjects: 156
Study: 11896309

Group type: EXPERIMENTAL
Intervention: Pentastarch
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hetastarch
Number of subjects: 0
Study: 10610046

Group type: EXPERIMENTAL
Intervention: Prenatal irradiation
Number of subjects: 50
Study: 8951516

Group type: EXPERIMENTAL
Intervention: Laparoscopy-assisted procedure (LAP)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard midline incision (SMI)
Number of subjects: 30
Study: 2275936

Group type: EXPERIMENTAL
Intervention: Subconjunctival gentamicin
Number of subjects: 121

Group type: COMPARATOR
Intervention: Subconjunctival cefuroxime
Number of subjects: 121
Study: 7304259

Group type: EXPERIMENTAL
Intervention: Metrizamide
Number of subjects: 30

Group type: COMPARATOR
Intervention: Metrizoate
Number of subjects: 30
Study: 30845349

Group type: EXPERIMENTAL
Intervention: Rhamnose
Number of subjects: 0
Study: 28992377

Group type: EXPERIMENTAL
Intervention: Active ABM training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham training
Number of subjects: 60
Study: 24045634

Group type: EXPERIMENTAL
Intervention: Lode stationary bicycle ergometer (SBE)
Number of subjects: 10

Group type: COMPARATOR
Intervention: PowerTap Pro+ (BPT)
Number of subjects: 10
Study: 25108708

Group type: EXPERIMENTAL
Intervention: Bedtime before 8:30 pm (n=14)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bedtime after 8:30 pm (n=6)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Participants dependent on nursing care for nighttime ADLs (n=9)
Number of subjects: 20
Study: 22007933

Group type: EXPERIMENTAL
Intervention: Combined planning and self-efficacy intervention
Number of subjects: 883

Group type: COMPARATOR
Intervention: Waiting-list control condition
Number of subjects: 883
Study: 20231115

Group type: EXPERIMENTAL
Intervention: High preexposure condition (10 clips showing strong pain)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-exposure control
Number of subjects: 0
Study: 16958129

Group type: EXPERIMENTAL
Intervention: 4-session depression intervention
Number of subjects: 145

Group type: COMPARATOR
Intervention: Measurement-only condition (Control)
Number of subjects: 145
Study: 16421350

Group type: EXPERIMENTAL
Intervention: After-school program (intervention group attending at least 40% of sessions)
Number of subjects: 447
Study: 11726677

Group type: EXPERIMENTAL
Intervention: Three response choices
Number of subjects: 60

Group type: COMPARATOR
Intervention: Five response choices
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Self-report feelings questionnaire
Number of subjects: 60
Study: 9667296

Group type: EXPERIMENTAL
Intervention: 10 microg sufentanil
Number of subjects: 10

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 10
Study: 7544628

Group type: EXPERIMENTAL
Intervention: G-CSF administration starting on day 0 (group A)
Number of subjects: 75

Group type: COMPARATOR
Intervention: G-CSF administration starting on day +7 (group B)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: G-CSF administration (both groups)
Number of subjects: 75
Study: 2655719

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Reduced REM latency (2-night mean ≤ 65.0 min)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Nonreduced REM latency
Number of subjects: 42
Study: 550376

Group type: EXPERIMENTAL
Intervention: 250 micrograms salbutamol (bolus intravenous injection)
Number of subjects: 32
Study: 30661551

Group type: EXPERIMENTAL
Intervention: MATCH (modular evidence-based treatment)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: MATCH strategies (Problem Solving and Relaxation skills)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Supplemental content (assessing and empathic listening)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Provider responses
Number of subjects: 34
Study: 28194410

Group type: EXPERIMENTAL
Intervention: Multipath NMES
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conventional NMES
Number of subjects: 12
Study: 26475805

Group type: EXPERIMENTAL
Intervention: Modified paramedian interlaminar (mPI) approach
Number of subjects: 62

Group type: COMPARATOR
Intervention: Transforaminal (TF) approach
Number of subjects: 62
Study: 23370978

Group type: EXPERIMENTAL
Intervention: 4% lidocaine spray
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0.9% saline (control)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Intracuff alkalinized 2% lidocaine
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 120
Study: 20582610

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser and SRP
Number of subjects: 22
Study: 20027938

Group type: EXPERIMENTAL
Intervention: EpiCeram
Number of subjects: 121

Group type: COMPARATOR
Intervention: Fluticasone propionate cream (Cutivate)
Number of subjects: 121
Study: 19839994

Group type: EXPERIMENTAL
Intervention: Risperidone 0.5-2.5 mg/day
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Risperidone 3-6 mg/day
Number of subjects: 169

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 169
Study: 15898029

Group type: EXPERIMENTAL
Intervention: Medial canthus single-injection peribulbar anesthesia
Number of subjects: 100

Group type: COMPARATOR
Intervention: Double-injection peribulbar anesthesia
Number of subjects: 100
Study: 12407030

Group type: EXPERIMENTAL
Intervention: Hysteroscopic vaporizing electrode procedure
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Laser treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Newer second generation techniques
Number of subjects: 0

Group type: COMPARATOR
Intervention: All techniques compared
Number of subjects: 0
Study: 9615558

Group type: EXPERIMENTAL
Intervention: Standard care plus daily OMT (10 to 20 minutes daily)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 14
Study: 7648588

Group type: EXPERIMENTAL
Intervention: CO2 gas (n = 41)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Low osmolar contrast material (Omnipaque 240 mgI/ml) (n = 33)
Number of subjects: 74
Study: 2669120

Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole
Number of subjects: 15

Group type: COMPARATOR
Intervention: Low-lactose diet
Number of subjects: 15
Study: 338089

Group type: EXPERIMENTAL
Intervention: Prophylactic low dose subcutaneous calcium heparin (dose based on body weight)
Number of subjects: 292

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 292
Study: 11474245

Group type: EXPERIMENTAL
Intervention: CDDP given before 5-FU
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: CDDP given after 5-FU
Number of subjects: 83

Group type: COMPARATOR
Intervention: Both regimens (CDDP before and after 5-FU)
Number of subjects: 83
Study: 30157383

Group type: EXPERIMENTAL
Intervention: Bacteriophage treatment (15 mg capsule containing 4 strains of bacteriophages)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 30055199

Group type: EXPERIMENTAL
Intervention: Planned care for obesity and risk reduction (PCORR)
Number of subjects: 262

Group type: COMPARATOR
Intervention: Enhanced usual care (EUC)
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: PCORR
Number of subjects: 262

Group type: COMPARATOR
Intervention: EUC
Number of subjects: 262
Study: 27043237

Group type: EXPERIMENTAL
Intervention: Probiotics (Bacillus subtilis and Enterococcus faecalis) 0.5 g three times daily through a nasogastric feeding tube plus standard preventive strategies
Number of subjects: 235

Group type: COMPARATOR
Intervention: Standard preventive strategies alone
Number of subjects: 235

Group type: EXPERIMENTAL
Intervention: Probiotics (Bacillus subtilis and Enterococcus faecalis)
Number of subjects: 235
Study: 25389284

Group type: EXPERIMENTAL
Intervention: Supervised Exercise (SE)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Stenting (ST)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Optimal Medical Care (OMC)
Number of subjects: 98
Study: 22547591

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel plus carboplatin (nab-PC)
Number of subjects: 1052

Group type: COMPARATOR
Intervention: solvent-based paclitaxel plus carboplatin (sb-PC)
Number of subjects: 1052
Study: 21416916

Group type: EXPERIMENTAL
Intervention: Pérez‐Olmedo protocol (n = 14)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Williams protocol (n = 15)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Jeffrey Saal protocol (n = 13)
Number of subjects: 42
Study: 17534786

Group type: EXPERIMENTAL
Intervention: Cold water immersion (15-min at 13-14 degrees C)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (passive rest)
Number of subjects: 17
Study: 16215304

Group type: EXPERIMENTAL
Intervention: S-R plication
Number of subjects: 78

Group type: COMPARATOR
Intervention: Nesbit procedure
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: S-R plication and Nesbit procedure
Number of subjects: 78
Study: 12177541

Group type: EXPERIMENTAL
Intervention: 80 mg methylprednisolone acetate (Depomedrol)
Number of subjects: 61

Group type: COMPARATOR
Intervention: 2 mL saline (control)
Number of subjects: 61
Study: 10459686

Group type: EXPERIMENTAL
Intervention: Trazodone 100 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trazodone 50 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trazodone (50-100 mg/day)
Number of subjects: 0
Study: 7776455

Group type: EXPERIMENTAL
Intervention: Ileal low pressure reservoir using the Goodwin cup‐patch principle combined with an afferent ileal tubular segment
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ileal low pressure reservoir
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Upper tract surveillance with excretory urography, renal ultrasound and serum creatinine estimation
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Video urodynamics
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Surgical technique of ileal low pressure reservoir with afferent isoperistaltic ileal segment
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Functional results of the bladder substitute
Number of subjects: 100
Study: 2772366

Group type: EXPERIMENTAL
Intervention: Propranolol (PPL) (160‐240 mg/day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Pindolol (PDL) and Clopamide (CLP) (PDL 10 mg, CLP 5 mg per tablet, 1-3 tablets based on blood pressure response)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCT) (150‐100 mg/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 342149

Group type: EXPERIMENTAL
Intervention: Zinc sulphate treatment
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Initial low serum zinc
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: High serum zinc
Number of subjects: 42
Study: 30656648

Group type: EXPERIMENTAL
Intervention: Goal-Directed Therapy (GDT)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Routine Fluid Treatment (RFT)
Number of subjects: 149
Study: 29991358

Group type: EXPERIMENTAL
Intervention: Prolonged exposure therapy
Number of subjects: 63

Group type: COMPARATOR
Intervention: Supportive counselling
Number of subjects: 63
Study: 26944938

Group type: EXPERIMENTAL
Intervention: Prescription Interactive Voice Response (IVR) Talking Prescriptions (Talking Rx) and SMS reminders
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 200
Study: 24566877

Group type: EXPERIMENTAL
Intervention: STOPP recommendations made by the inpatient geriatric consultation team (IGCT) to ward physicians to discontinue potentially inappropriate medications (PIMs)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Standard geriatric advice (Control)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Follow-up of patients after discharge
Number of subjects: 146
Study: 22894574

Group type: EXPERIMENTAL
Intervention: Tofacitinib 0.5 mg
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Tofacitinib 3 mg
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Tofacitinib 15 mg
Number of subjects: 194

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 194
Study: 21114345

Group type: EXPERIMENTAL
Intervention: Dialectical behavior therapy (DBT)
Number of subjects: 16
Study: 17692985

Group type: EXPERIMENTAL
Intervention: Pegylated‐interferon alpha‐2b (1 microg/kg/week)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Pegylated‐interferon plus ribavirin (800 mg/day up to 52 weeks)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Genotype 1 with low viral load at start of therapy
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Patients with sustained virological response
Number of subjects: 102
Study: 15822043

Group type: EXPERIMENTAL
Intervention: Ulinastatin (150,000 U) administered by intravenous infusion for 10 minutes before ERCP
Number of subjects: 406

Group type: COMPARATOR
Intervention: Placebo administered by intravenous infusion for 10 minutes before ERCP
Number of subjects: 406
Study: 11176594

Group type: EXPERIMENTAL
Intervention: Minimal incision palatopharyngoplasty
Number of subjects: 72

Group type: COMPARATOR
Intervention: Minimal incision palatopharyngoplasty with individualized pharyngeal flap or sphincter pharyngoplasty
Number of subjects: 72
Study: 9084463

Group type: EXPERIMENTAL
Intervention: CP-148,623 (300 mg twice a day; n = 12)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo (n = 13)
Number of subjects: 25
Study: 7941580

Group type: EXPERIMENTAL
Intervention: Continuous phototherapy
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: Intermittent phototherapy
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: Exchange transfusion and phototherapy
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: Phototherapy (all methods)
Number of subjects: 596
Study: 3345017

Group type: EXPERIMENTAL
Intervention: 50 g activated charcoal
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 50 g activated charcoal-sorbitol solution
Number of subjects: 8

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 8
Study: 30358871

Group type: EXPERIMENTAL
Intervention: GLP-1 antagonist exendin 9-39
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 28962966

Group type: EXPERIMENTAL
Intervention: Selective Laser Trabeculoplasty (SLT)
Number of subjects: 72
Study: 26154030

Group type: EXPERIMENTAL
Intervention: EXPL (1.61 g protein/100 kcal; modified bovine whey proteins with caseinoglycomacropeptide removed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: CTRL (2.15 g protein/100 kcal; unmodified bovine milk protein with a whey/casein ratio of 60/40)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: BF (breast-fed infants)
Number of subjects: 0
Study: 23453018

Group type: EXPERIMENTAL
Intervention: Modified LiuJunZi decoction
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study: 21625125

Group type: EXPERIMENTAL
Intervention: Electronic data capture
Number of subjects: 52

Group type: COMPARATOR
Intervention: Handwritten data capture
Number of subjects: 52
Study: 18343200

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 18
Study: 16354710

Group type: EXPERIMENTAL
Intervention: Dietetic assistants (DAs)
Number of subjects: 318
Study: 12721161

Group type: EXPERIMENTAL
Intervention: Ovulation induction (OI) with clomiphene (CC) or gonadotrophin (FSH) and intrauterine insemination (IUI)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: FSH/IUI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ovulation induction (OI) with IUI
Number of subjects: 0

Group type: COMPARATOR
Intervention: IVF
Number of subjects: 0
Study: 10856867

Group type: EXPERIMENTAL
Intervention: Hypothermic CPB
Number of subjects: 50

Group type: COMPARATOR
Intervention: Normothermic CPB
Number of subjects: 50
Study: 9416653

Group type: EXPERIMENTAL
Intervention: Neuroleptic dosage reduction (tapered by 25% each month)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Neuroleptic-free patients (n=19)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Maintenance on neuroleptics (n=22)
Number of subjects: 27
Study: 7962514

Group type: EXPERIMENTAL
Intervention: Ultrasound screening for hip dysplasia
Number of subjects: 4459

Group type: EXPERIMENTAL
Intervention: Interobserver study of ultrasound method
Number of subjects: 4459

Group type: EXPERIMENTAL
Intervention: Incidence of late-detected hip dysplasia
Number of subjects: 4459
Study: 3298418

Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 31963802

Group type: EXPERIMENTAL
Intervention: High dose (HD: 13 g of EAAS BID)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Low dose (LD: 8 g of EAAS BID)
Number of subjects: 25
Study: 29196046

Group type: EXPERIMENTAL
Intervention: Open-label intravenous ceftriaxone 2000 mg in addition to usual care
Number of subjects: 2672

Group type: COMPARATOR
Intervention: Usual care (fluid resuscitation and supplementary oxygen)
Number of subjects: 2672
Study: 26597649

Group type: EXPERIMENTAL
Intervention: Bisexual targets
Number of subjects: 1379

Group type: EXPERIMENTAL
Intervention: Female bisexuality
Number of subjects: 1379

Group type: EXPERIMENTAL
Intervention: Views of bisexual people
Number of subjects: 1379
Study: 25404142

Group type: EXPERIMENTAL
Intervention: Op Volle Kracht (OVK)
Number of subjects: 1341

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1341
Study: 22540955

Group type: EXPERIMENTAL
Intervention: Drain group
Number of subjects: 93

Group type: COMPARATOR
Intervention: No-drain group
Number of subjects: 93
Study: 20118341

Group type: EXPERIMENTAL
Intervention: Subfascial endoscopic perforating surgery (SEPS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Percutaneous thermal ablation techniques (PAPS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sclerotherapy of ICPVs (liquid or foam)
Number of subjects: 0
Study: 18559416

Group type: EXPERIMENTAL
Intervention: Flaxseed supplementation
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Dietary fat restriction
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Flaxseed supplementation and dietary fat restriction combined
Number of subjects: 161
Study: 16899026

Group type: EXPERIMENTAL
Intervention: B-CPC (Toothbrushing with dentifrice followed by CPC mouthrinse)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: B-W-CPC (Toothbrushing with dentifrice followed by water rinse and then CPC mouthrinse)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: B-60 min.-CPC (Toothbrushing with dentifrice and waiting 60 min. prior to CPC mouthrinse)
Number of subjects: 29

Group type: COMPARATOR
Intervention: B-W (Toothbrushing with dentifrice followed by a water rinse, negative control)
Number of subjects: 29